This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
This book offers a progress report on efforts to meet the challenges faced by ovarian cancer patients and their doctors. It provides a current perspective on therapeutic developments as a partnership between laboratory-based and clinical-based researchers.
1 Existing treatment for ovarian cancer: recent advances and description of unmet needs S Banerjee M Bookman M Gore 2 Discovery of novel targets J Farley M Birrer 3 Anti-angiogenesis - update on its application in ovarian cancer J Hasan G Jayson 4 Targeting the PI3K/AKT pathway E Stronach A Cheraghchi-Bashi M Chen H Gabra 5 Inhibition of the SRC oncogene; potential in ovarian cancer LY Han AK Sood 6 Tumour specific synthetic lethality; targeting BRCA gene dysfunction TA Yap SB Kaye A Ashworth A Tutt 7 Inhibition of cytokines and chemokines in ovarian cancer J Coward F Balkwill 8 Potential for inhibition of membrane receptors (EGF, IGF, c-MET, and others) LP Martin JJ Perkins R Schilder 9 An epigenetic approach to ovarian cancer R Brown N Chapman-Rothe R Glasspool 10 Immunotherapy; update on its application in ovarian cancer S Ghaem-Maghami M Gore 11 Ovarian cancer progenitor/stem cells; therapeutic potential S Murphy A Berchuck 12 Potential for ?-folate receptor targeted treatment for ovarian cancer CHM Ng A Jackman 13 New insights into tubulin binders J Brenton
1 Existing treatment for ovarian cancer: recent advances and description of unmet needs S Banerjee M Bookman M Gore 2 Discovery of novel targets J Farley M Birrer 3 Anti-angiogenesis - update on its application in ovarian cancer J Hasan G Jayson 4 Targeting the PI3K/AKT pathway E Stronach A Cheraghchi-Bashi M Chen H Gabra 5 Inhibition of the SRC oncogene; potential in ovarian cancer LY Han AK Sood 6 Tumour specific synthetic lethality; targeting BRCA gene dysfunction TA Yap SB Kaye A Ashworth A Tutt 7 Inhibition of cytokines and chemokines in ovarian cancer J Coward F Balkwill 8 Potential for inhibition of membrane receptors (EGF, IGF, c-MET, and others) LP Martin JJ Perkins R Schilder 9 An epigenetic approach to ovarian cancer R Brown N Chapman-Rothe R Glasspool 10 Immunotherapy; update on its application in ovarian cancer S Ghaem-Maghami M Gore 11 Ovarian cancer progenitor/stem cells; therapeutic potential S Murphy A Berchuck 12 Potential for ?-folate receptor targeted treatment for ovarian cancer CHM Ng A Jackman 13 New insights into tubulin binders J Brenton
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826
